USFDA: New and Generic Drug Approvals: 29 SEP 2014

New and Generic Drug Approvals

September 29, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Abilify Maintena KitaripiprazoleFor Suspension, Extended Release;IntramuscularOtsuka Pharm Co LtdManufacturing Change or Addition
AlinianitazoxanideFor Suspension;OralRomarkManufacturing Change or Addition
ClozarilclozapineTablet;OralNovartisLabeling Revision
CortrosyncosyntropinInjectable;InjectionAmphastar Pharms IncManufacturing Change or Addition
Cozaarlosartan potassiumTablet;OralMerck Sharp DohmeLabeling Revision
Dextrose 5% In Plastic ContainerdextroseInjectable;InjectionB BraunManufacturing Change or Addition
Flo-Predprednisolone acetateSuspension;OralTaroManufacturing Change or Addition
Fludarabine Phosphatefludarabine phosphateInjectable;InjectionSandozManufacturing Change or Addition
Hyzaarhydrochlorothiazide; losartan potassiumTablet;OralMerck Sharp DohmeLabeling Revision
LumiganbimatoprostSolution/Drops;OphthalmicAllerganLabeling Revision
LumiganbimatoprostSolution/Drops;OphthalmicAllerganLabeling Revision
Nexteroneamiodarone hydrochlorideInjectable;InjectionBaxter HlthcareManufacturing Change or Addition
Relistormethylnaltrexone bromideInjectable;SubcutaneousSalix PharmsEfficacy Supplement with Clinical Data to Support
Relistormethylnaltrexone bromideSolution;SubcutaneousSalix PharmsEfficacy Supplement with Clinical Data to Support
SkelaxinmetaxaloneTablet;OralKing PharmsManufacturing Change or Addition
Sodium Chloride 0.9% In Sterile Plastic Containersodium chlorideSolution For Slush;IrrigationBaxter HlthcareManufacturing Change or Addition
VersaclozclozapineSuspension;OralJazz Pharms IiiManufacturing Change or Addition
Voltarendiclofenac sodiumGel;TopicalNovartisManufacturing Change or Addition
Zingolidocaine hydrochlorideSystem;IntradermalPowder PharmsManufacturing Change or Addition
ZoviraxacyclovirOintment;TopicalValeant BermudaManufacturing Change or Addition

No comments:

Post a Comment